Continuous Manufacturing Poised to Disrupt Pharma Sector
This article was originally published in The Gold Sheet
Executive Summary
As pharmaceutical companies begin taking advantage of continuous manufacturing, they are realizing how it can transform an industry rooted in batch processing. Now they have drafted a survival guide.
You may also be interested in...
Why Advanced Manufacturing Technologies Haven’t Prevented Drug Shortages – And How They Could
A decade later, another MIT retreat explores factors behind slow adoption of technologies touted in the first – and how the barriers could be overcome to deliver higher-quality, more shortage-proof generic drugs.
Why Advanced Manufacturing Technologies Haven’t Prevented Drug Shortages – And How They Could
A decade later, another MIT retreat explores factors behind slow adoption of technologies touted in the first – and how the barriers could be overcome to deliver higher-quality, more shortage-proof generic drugs.
CMC And GMP Updates In Brief: Continuous Manufacturing, Accelerated CMC Reviews
ICH general assembly adopts guidelines on continuous manufacturing and risk management; US FDA opens pilot project to expedite CMC reviews for products with accelerated review timelines; other recent topics include quality maturity inspections and compounding standards.